A physician-created library of questions to help you understand, prepare, and advocate for yourself at every stage
This comprehensive collection of questions is designed to empower you with knowledge and help you have more meaningful conversations with your healthcare team. Whether you've just been diagnosed, are living with a history of skin cancer, or want to focus on prevention, these questions can guide your learning journey.
Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your own clinician for personalized guidance.
Starter questions to help you understand your diagnosis and what comes next.
Melanoma is a cancer of melanocytes, the cells that give skin its pigment. It's less common than basal cell and squamous cell carcinoma, but more dangerous because it can spread to lymph nodes and organs if it isn't caught early. Most melanomas show up as a new or changing mole. Our melanoma overview explains the basics.
Depth predicts behavior. The deeper melanoma cells reach into the skin, the more access they have to blood vessels and lymphatic channels that can carry them elsewhere. Pathologists measure this in millimeters as the Breslow depth, and it's the strongest single factor in staging, in deciding whether you need a sentinel lymph node biopsy, and in estimating outlook.
Staging describes how far melanoma has traveled. Stage 1 means it's still confined to the skin and thin, with a high cure rate after surgery alone. Stage 3 means melanoma cells have reached nearby lymph nodes but not distant organs, so treatment usually adds immunotherapy or targeted therapy after surgery. Stage 2 sits between them. Our stage-meaning guide walks through each one.
Melanoma begins in melanocytes along the border between the epidermis, the outer layer of skin, and the dermis beneath it. Early on it spreads sideways and is easy to cure. If it isn't removed, it can grow downward into the dermis, where blood and lymph vessels give cells a route to lymph nodes and distant organs. That's why depth matters so much.
Melanoma is the fifth most common cancer in the United States, with roughly 100,000 new invasive cases each year. The biggest risk factor is ultraviolet exposure from sun and tanning beds, especially blistering sunburns. Others include fair skin, many or unusual moles, a personal or family history of melanoma, and a weakened immune system. Sun protection lowers the risk.
Your doctor reviews the pathology report, which lists the melanoma's thickness, ulceration, and other features. Most people then have a wide local excision to remove extra tissue around the biopsy site with a safe margin. Depending on thickness, a sentinel lymph node biopsy may be done at the same time. Thin, early melanomas often need nothing more. See what to expect after diagnosis.
A dermatologist usually finds the melanoma and does the first biopsy. A surgical oncologist or dermatologic surgeon performs the wide excision and any lymph node surgery. A pathologist examines the tissue and writes the report. For advanced disease, a medical oncologist manages immunotherapy or targeted therapy, and a radiation oncologist may help. Learn how to find a melanoma specialist.
They base it on the melanoma's stage. For thin, early-stage melanoma with no symptoms, scans rarely help and can cause false alarms, so a skin and lymph node exam is usually enough. Thicker tumors, a positive sentinel lymph node biopsy, or symptoms like pain or weight loss prompt imaging such as CT, PET-CT, or MRI. Staging guides the choice.
"Clear margins" means the removed tissue has a border of normal skin all the way around the tumor. After surgery a pathologist checks the edges of the specimen under a microscope. If no melanoma cells touch the cut edge, margins are "clear" or "negative" and the tumor was fully removed. "Positive" margins mean cells reach the edge, so more surgery is usually advised. Margins appear on your pathology report.
Surgery for melanoma is important but rarely an emergency. Most people have their wide excision within a few weeks of diagnosis. Timing depends on booking the right surgeon, coordinating a sentinel lymph node biopsy if one is planned, other health conditions, and sometimes arranging a second opinion. A short, planned wait to line up the right team does not worsen outcomes.
For melanoma confined to the skin, surgery is the mainstay. A wide local excision removes the site with a margin of healthy tissue, usually in the office or as day surgery, and cures most thin melanomas. A sentinel lymph node biopsy may be added once the tumor is about 0.8 mm thick or thicker. Radiation or drug therapy is seldom needed this early. See our treatment options guide.
Both remove the lesion with a clear margin. Wide local excision takes the visible spot plus a measured rim of normal skin in one step, and the edges are checked afterward. Mohs surgery removes tissue in thin layers, mapping and checking each layer under the microscope during the same visit, which spares healthy skin on the face. For melanoma in situ, either can be appropriate; your surgeon recommends which fits.
The main trigger is tumor thickness. A sentinel lymph node biopsy is generally offered once a melanoma is around 0.8 mm deep, or thinner but ulcerated, and discussed for thicker tumors. Features like a high mitotic rate can tip the decision. It's usually skipped for very thin melanomas, where node spread is unlikely. Your age and other health conditions also count. See our sentinel node guide.
Both treat melanoma that has spread or has a high risk of coming back. Immunotherapy helps your own immune system recognize and attack melanoma cells, and can give long-lasting control. Targeted therapy uses pills that block a specific mutation, most often BRAF, to shrink tumors quickly. The aim is to lower recurrence risk after surgery or to control advanced disease. See our treatment options guide.
With immunotherapy, most side effects come from an over-active immune system: fatigue, rash, itching, diarrhea, or thyroid changes. Most are mild, but some need steroids, so report new symptoms early. Targeted therapy more often brings fever, joint aches, rash, and fatigue that ease when the dose is adjusted. Many people keep working through treatment while the oncology team checks bloodwork regularly. See our treatment options guide.
Fear is normal, especially in the weeks before staging is finished. Many people find it helps to focus on the next concrete step, bring someone to appointments, and write questions down beforehand. Ask your team about a counselor or support group; most cancer centers offer them at no cost. Limit late-night searching, keep daily routines, and lean on people you trust.
Keep it simple and honest. Many people say melanoma is a serious skin cancer that the doctors caught and are treating, and that surgery removes it. With young children, short, calm explanations work best: name the illness, say who is helping, and reassure them it isn't their fault and isn't contagious. Invite questions and answer them in small doses over time.
After a wide local excision, expect a line of stitches, some bruising, and mild soreness for a week or two. You'll get wound-care instructions and usually return in one to two weeks for stitch removal and the final pathology result. Most people return to desk work within days, avoiding heavy lifting or stretching the area for a few weeks. Larger wounds may need a skin graft or flap. See what to expect after diagnosis.
Yes. Helpful questions include: How long will the scar be, and which way will it run? Will you close it directly, or might it need a graft or flap? What helps it heal — scar massage, taping, sun protection? When can I exercise again? What is normal, and what signals infection? Asking before surgery lets you plan clothing and time off work.
Keep one folder or binder — paper or digital — for pathology reports, imaging, and visit summaries. Sign up for each office's patient portal and save results as they post. Keep a running list of dates, doctors, and next steps, and bring it to every visit. Jot down questions as they occur to you. A single point person, such as a spouse, can help track everything.
Good openers: What is my exact diagnosis and stage? How thick was the melanoma, and was it ulcerated? What surgery do you recommend, and will I need a sentinel lymph node biopsy? Do I need any scans? What are the next steps and the expected timeline? Who do I call with problems? Ask for the plan in writing and bring someone to take notes.
Bring your biopsy pathology report, plus the slides or tissue block if you were treated elsewhere, and any earlier skin-cancer history or photos of the spot. List your medications, allergies, and past surgeries, and note any family history of melanoma. Add insurance details and a written list of questions. The actual pathology material lets a new team confirm the diagnosis without repeating the biopsy.
Ask for a copy ahead of time and read it alongside our pathology report guide. In the visit, ask the doctor to translate each line — Breslow thickness, ulceration, margins, mitotic rate, and stage. Say it back in your own words, then ask, "What does this mean for my treatment and outlook?" Request a written summary, and feel free to ask again next time.
Pros: high-volume centers re-read your pathology, confirm the stage, offer the newest surgical and drug options, and can open access to clinical trials, and many patients simply feel more confident. Cons: added travel, appointments, and cost, a short delay, and sometimes conflicting advice to sort out. Most melanoma specialists expect and welcome second opinions, and a brief planned delay is safe. Learn how to find a melanoma specialist.
Bring a notebook or use your phone, and record the date, the main points, and any numbers such as thickness or stage. Bring a second person to listen and write while you focus on the conversation. Ask permission to make an audio recording; most doctors agree. Afterward, read the visit summary in the patient portal and send follow-up questions there. Keep it all in one place.
Advanced questions for long-term follow-up, prevention, and peace of mind.
Follow-up depends on stage. After an early, thin melanoma, many people see a dermatologist every 6–12 months for a full skin check. Higher-stage melanoma often means visits every 3–6 months for the first few years, sometimes with imaging, then spacing out over time. Most doctors continue skin exams for life. Our guide on what to expect after diagnosis covers the rhythm.
Recurrence risk is highest in the first two to three years after treatment, which is why check-ups are most frequent then. The risk gradually falls the longer you stay clear, though it never reaches zero, and late recurrences can occur years later, especially with thicker melanomas. Thinner, earlier-stage melanomas carry a much lower risk overall. Your Breslow depth and stage shape your personal numbers.
For early-stage melanoma, follow-up is usually just a physical skin and lymph-node exam, no routine scans. For stage 2B and higher, doctors may add imaging such as CT, PET-CT, or brain MRI every 6–12 months for a few years to catch spread early. Blood tests aren't reliable for tracking melanoma. Our stage-meaning guide explains how stage drives these choices.
Watch for a new lump or firm nodule under or near the surgical scar, a change in scar color, or a new pigmented spot beside it. Swollen, firm lymph nodes in the neck, armpit, or groin that don't settle are another sign. Fatigue, weight loss, or a lasting cough or headache matter too. Our melanoma overview explains how it spreads.
A recurrence is the original melanoma regrowing, near the scar, in nearby lymph nodes, or at a distant site, and it carries the same stage history. A new primary melanoma is a completely separate cancer that starts fresh somewhere else on the skin. People who've had one melanoma have a higher chance of a second, which is why long-term follow-up stays lifelong.
Once a month, in good light and using a full-length and a hand mirror, check every area, including your scalp, ears, back, buttocks, soles, and between toes. Look for anything new, changing, or different from your other spots, and feel your scar and nearby lymph nodes for lumps. A partner can check hard-to-see places. Our guide to warning signs of change lists what to flag.
Run your fingertips over and around the scar every month. You're feeling for a new bump, thickening, or firm nodule in or under the skin, and looking for new pigment, redness, or a sore that won't heal. In the nearby lymph-node basin, feel for swollen or hard nodes. Most changes are harmless scar tissue, but anything new that grows or persists over a few weeks deserves a call.
Professional total-body photography, taken in a clinic and reviewed by your dermatologist, is genuinely useful for anyone with many moles or a melanoma history; it gives a baseline to compare against. Smartphone mole-mapping apps can help you organize your own photos, but consumer "AI" risk scores aren't accurate enough to rule cancer in or out. Use them as a tracking tool, not a diagnosis — see tracking changes over time.
Two rules help. The ABCDEs: Asymmetry, an irregular Border, uneven Color, Diameter over about 6 mm, and any Evolving change in size, shape, or color. The "ugly duckling" sign: a spot that stands out because it doesn't match your other moles. Change over weeks to months matters more than a single feature. When in doubt, have it looked at. Our guide on what makes a mole atypical goes deeper.
Call promptly for a new lump near your scar or in a lymph-node area, a mole that changes quickly, a spot that bleeds or won't heal, or new symptoms like a persistent cough, headache, bone pain, or unexplained weight loss. Routine things, one slightly dry patch or a stable freckle, can wait for your scheduled visit. When unsure, a quick call is always reasonable.
The biggest levers are sun habits: seek shade at midday, wear a broad-brimmed hat and UPF clothing, apply SPF 30+ to exposed skin daily, and never use tanning beds. Do a monthly self-exam, keep every dermatology appointment, don't smoke, and treat any suspicious spot early. None of this guarantees prevention, but together it meaningfully cuts risk. Our prevention guide has the details.
Think in layers. Shade and tightly woven or UPF-rated clothing block most UV before it reaches skin and don't wear off. Sunscreen covers what clothing can't, the face, ears, neck, and hands, but only if you use enough and reapply every two hours. A wide-brimmed hat and UV-blocking sunglasses finish the job. No single method is complete; combined, they add up.
Most dermatologists advise getting vitamin D from food and supplements rather than deliberate sun exposure, especially after a melanoma. The amount of UV that raises vitamin D also damages skin, and there's no "safe" tanning dose for someone at higher risk. A daily vitamin D supplement, with a blood test to guide the dose, achieves the same goal without the UV. Discuss the dose with your doctor.
Nicotinamide is a form of vitamin B3, sold over the counter as a supplement (not the same as niacin, which causes flushing). In studies of people with a history of non-melanoma skin cancers, 500 mg twice daily reduced new basal and squamous cell cancers by about a fifth. Evidence for melanoma prevention is weaker. Many dermatologists suggest it for high-risk patients; ask whether it fits your situation.
A weakened immune system, from organ-transplant drugs, long-term immune-suppressing medicines, HIV, or blood cancers like leukemia, raises the risk of new skin cancers and can make them behave more aggressively. Some blood-pressure and antibiotic drugs increase sun sensitivity. Tell your dermatologist about every medication and condition; it changes how often you should be screened and how quickly spots are treated.
Fear of recurrence is one of the most common lasting effects of a cancer diagnosis, and it tends to spike before check-ups and scans. People manage it by keeping to a clear follow-up plan so vigilance has boundaries, learning which symptoms actually warrant a call, staying connected to others who understand, and using counseling or structured techniques when the worry disrupts daily life. It usually eases with time.
A workable balance is doing the few things that matter and then letting go: one monthly self-exam on a set date, keeping scheduled dermatology visits, and protecting your skin from the sun daily. Outside those, try not to re-check spots every day, which tends to raise anxiety without adding safety. Write down real changes to discuss at your next visit rather than researching them at midnight.
Yes. The Melanoma Research Foundation and AIM at Melanoma both run peer forums, virtual meet-ups, and patient-to-patient matching programs. The American Cancer Society offers a general survivor community and a helpline. Many cancer centers host in-person or online groups led by a social worker. Ask your care team for a local referral, and choose a group whose tone, informational or emotional, fits what you need.
Many survivors find it helps to decide in advance how much to share, and with whom, so each conversation is a choice rather than a reaction. A short, prepared line — "I had melanoma, it was treated, and I get regular checks" — answers most questions and closes the topic if you want. You can be a person who had melanoma without it being your headline.
People often mark the day treatment ended, the first clear skin check, each cancer-free scan, and the one- and five-year anniversaries of surgery. Smaller wins count too: finishing a course of a topical medicine, a healed scar, getting through a check-up with less dread than last time. Naming these moments helps shift the story from "waiting for bad news" to steady progress.
Immunotherapy that unleashes the immune system, and targeted drugs for melanomas with a BRAF mutation, have transformed outcomes for advanced disease over the past decade. Newer directions include giving these drugs before surgery, an mRNA vaccine tailored to a person's tumor, and cell therapies. Trials also test whether earlier-stage patients benefit. Ask your oncologist what's open to you, or see melanoma clinical trials.
Testing looks for inherited gene changes, most often CDKN2A, that run in families with several melanoma cases, melanoma plus pancreatic cancer, or a person who's had multiple primary melanomas. A blood or saliva sample is analyzed, and a genetic counselor explains what a result means for you and relatives. Most melanoma isn't hereditary, so testing isn't routine, but it can guide screening for high-risk families.
First-degree relatives — parents, siblings, children — of someone with melanoma have roughly double the average risk, so a baseline full-skin exam with a dermatologist is worthwhile, repeated yearly if they have many or atypical moles. Everyday steps are the same for them as for you: daily sun protection, no tanning beds, and a monthly self-check. Our atypical moles guide helps them know what to watch.
Teledermatology — sending photos or doing a video visit — works well for checking a single spot quickly, reviewing a healing scar, or triaging whether you need to come in. It doesn't replace a periodic in-person full-body exam, where a dermatologist uses a dermatoscope and feels lymph nodes. AI tools that flag suspicious images are emerging but still assist the doctor rather than decide. Total-body photography remains the most proven aid.
Pick two or three trustworthy sources — a major cancer organization, your cancer center's materials, and this site — and check them on a schedule rather than searching whenever anxiety strikes. Bring questions to your appointments; your team can tell you which headlines actually apply to your stage. Skip forums when you're feeling fragile. Our melanoma overview is a steady place to start.
Essential questions for understanding your BCC and treatment options.
Basal cell carcinoma is the most common skin cancer. It starts in the basal cells at the bottom of the outer skin layer, usually on sun-exposed areas like the face, ears, and neck. Unlike melanoma, it very rarely spreads to other organs, and it grows more slowly than squamous cell carcinoma. Left untreated, though, it can invade nearby tissue. Our basal cell carcinoma overview covers the basics.
Slow growth means you usually have time to plan treatment rather than rush, and it's a big reason basal cell carcinoma is so rarely life-threatening. It doesn't mean you can ignore it. Over months to years an untreated tumor can enlarge, ulcerate, and destroy nearby skin, cartilage, or bone, making later removal harder and more disfiguring. Prompt treatment while it's small keeps the procedure simple. See how BCC spreads and why it's still serious.
It means metastasis — cancer cells breaking away and traveling through blood or lymph to lymph nodes or organs — happens in far fewer than 1 in 1,000 basal cell carcinomas. Almost all stay put as a local growth on the skin. That's why staging scans and lymph node checks aren't routine for BCC, unlike melanoma. The main risk is local damage if it's left alone.
Yes. The common subtypes are nodular (a pearly bump, often on the face), superficial (a flat pink patch, more common on the trunk), and infiltrative or morpheaform (scar-like, with roots that extend beyond what the eye sees). Nodular and superficial forms are usually straightforward to treat. Infiltrative and morpheaform types are more aggressive locally and often need Mohs surgery. Our guide to BCC types describes each one.
A dermatologist may strongly suspect BCC from its look and from dermoscopy (a lighted magnifier), but a skin biopsy is what confirms it. A small sample is numbed and removed, then a pathologist examines it under the microscope to identify the cancer and its subtype. That result guides which treatment fits. Biopsy is nearly always done before treatment. Our what a BCC biopsy means page explains the process.
Usually your dermatologist reviews the biopsy result with you, explains the subtype and location, and recommends a treatment — most often a minor in-office procedure scheduled within a few weeks. There's rarely a need for scans or blood tests. You'll get wound-care instructions afterward and a follow-up skin exam. Because a first BCC raises the odds of another, regular full-skin checks become part of your routine — our recurrence-prevention guide has details.
They weigh the subtype, size, and location, whether it's a first tumor or a recurrence, and your overall health and preferences. Aggressive subtypes or spots on the face usually get surgery, often Mohs, for the highest cure rate. Small, superficial tumors on the trunk may suit scraping and burning, cryotherapy, or a prescription cream. Cure rates and trade-offs differ. Our BCC treatment options compares them.
These labels predict how likely a tumor is to come back after treatment, not whether it will spread. High-risk features include an aggressive subtype under the microscope, larger size, location on the "mask" area of the face, ears, hands, or feet, poorly defined borders, a recurrent tumor, or a weakened immune system. High-risk BCCs usually get Mohs surgery for the best chance of a lasting cure.
After a tumor is removed, a pathologist checks the edges of the sample. "Clear" (negative) margins mean normal tissue surrounds the tumor, so it was likely all taken out. "Positive" margins mean cancer cells reach the cut edge, so some may remain and more treatment — another excision, Mohs, or occasionally radiation — is usually recommended. Our biopsy-meaning page explains report language.
Mohs surgery removes the tumor layer by layer, checking 100% of each layer's edges under a microscope during the same visit before closing the wound. That gives the highest cure rate while sparing the most healthy tissue — valuable on the face, where a standard excision samples only part of the margin and removes a wider safety border. It's favored for high-risk, recurrent, or cosmetically sensitive BCCs. See BCC treatment options.
It's done awake under local anesthesia in the office. The surgeon removes the visible tumor plus a thin margin, then you wait — often 30 to 60 minutes — while the tissue is mapped and read under the microscope. If any edge still shows cancer, only that area is re-excised, and the cycle repeats. Most cases finish in one to three rounds over a morning, ending with wound repair. Our recovery-after-surgery page covers what follows.
Creams such as imiquimod or 5-fluorouracil are applied at home for several weeks and leave no surgical scar, which appeals for small, superficial BCCs on the trunk or limbs. The trade-offs: cure rates are lower than surgery, the skin gets red, crusted, and sore during treatment, and margins can't be checked, so follow-up matters. They aren't used for nodular or facial tumors. Our treatment options page compares approaches.
For carefully chosen low-risk BCCs — small, superficial, away from the face — electrodesiccation and curettage (scraping then burning the base) cures roughly 90 to 95 percent, and cryotherapy (freezing with liquid nitrogen) is similar in expert hands. Both are quick and inexpensive but leave a pale, round scar and don't allow margin checking. They're avoided for aggressive subtypes or high-risk sites, where surgery is safer.
Radiation is an option when surgery isn't a good fit — for example, a frail or elderly patient, a tumor in a spot that's hard to reconstruct, or a patient who declines an operation. It's also given after surgery when margins stay positive or nerves are involved. It avoids cutting but needs many visits over weeks, can't check margins, and may age the treated skin. Our treatment options page lists when it's chosen.
Hedgehog inhibitors (vismodegib and sonidegib) are daily pills that block a signaling pathway most BCCs use to grow. They're reserved for the rare advanced cases — a tumor too large or deep for surgery and radiation, or one that has spread. They can shrink these tumors, but side effects like muscle cramps, taste loss, and hair thinning are common. Most people with BCC never need them. See spread and seriousness.
It helps to keep the odds in view: basal cell carcinoma is almost always cured by a single outpatient procedure and rarely threatens health. Write down your questions, bring someone to the appointment, and ask the office to walk you through the day step by step. Basic stress tools — sleep, movement, limiting late-night searching — matter too. Our BCC overview lays out what to expect.
A small removal closed with a few stitches typically means mild soreness, a bandage for a day or two, stitches out in one to two weeks, and a thin line that fades over months. Larger removals — or repairs using a skin flap or graft — bring more swelling, bruising, activity limits, and a longer-healing scar. Your team gives site-specific wound care. Our recovery-after-surgery page has a timeline.
Raise it before the procedure, not after. Ask where the scar will sit, how long it will be, which repair options exist, and whether Mohs would spare more tissue. Ask about scar-care steps — taping, silicone gel, sun protection, and when laser or revision could help if you're unhappy later. A good surgeon expects these questions and will plan the closure with your appearance in mind.
Yes — it's routine and expected, and BCC's slow growth means a short delay to get one is rarely a problem. A second dermatologist or a Mohs surgeon can confirm the biopsy reading and review whether surgery, radiation, or a topical option best fits your tumor, your other health conditions, and your priorities. Bring your pathology report and photos so the discussion is concrete.
Yes, ongoing. After a BCC, about 4 in 10 people develop another skin cancer within five years, so dermatologists usually schedule full-skin exams every 6 to 12 months, sometimes more often at first. Visits include checking the treated site for recurrence and scanning the rest of your skin for new spots. Monthly self-checks fill the gaps between visits. Our recurrence-prevention page explains the schedule.
Useful ones: What subtype and risk level is my BCC? Why this treatment over the others? What's its cure rate for a tumor like mine? What will the scar look like, and who does the repair? What are the risks and the recovery time? What happens if margins aren't clear? And how will we follow up? Our treatment options page can prime the conversation.
Ask for a copy and go through it with your dermatologist. Key lines are the diagnosis and subtype (nodular, superficial, infiltrative, morpheaform), the margin status (clear or involved), tumor size, and any mention of nerve or deep involvement. Ask the doctor to translate each phrase and say what it changes about your plan. Our biopsy-meaning page decodes the common terms.
Expect some soreness, mild swelling, and possibly a bruise around the site. You'll keep the wound covered, often apply plain petroleum jelly, and avoid heavy lifting or strenuous exercise for a week or two so the repair isn't strained. A little oozing early on is normal. Take acetaminophen if your surgeon okays it. Written instructions cover bathing and dressing changes. Our recovery-after-surgery page has a day-by-day guide.
Normal healing looks like gradually decreasing soreness, edges staying together, and a scab or pink new tissue forming. Warning signs to call about: spreading redness, warmth, increasing pain after day two or three, thick yellow-green pus, a bad smell, fever, or bleeding that won't stop with gentle pressure. Reopening of the wound also warrants a call. When in doubt, phone the office — they would rather hear from you.
Fresh scars sunburn easily and can darken permanently, so ask how long to keep the site fully shaded or taped, when you can apply sunscreen to it, and which SPF and formula suit healing skin. Also ask about protecting the rest of your skin, since sun exposure drove this cancer and raises the odds of the next. Our lifestyle and prevention page covers daily habits.
Questions for ongoing monitoring and reducing future risk.
After one basal cell carcinoma, most dermatologists schedule a full skin exam every 6 to 12 months, since roughly 4 in 10 people develop another within five years. People with several past skin cancers, large or aggressive tumors, or a weakened immune system are usually seen more often. Your dermatologist sets the interval and stretches it out as your skin stays clear. Our recurrence-prevention guide has more.
Recurrence means basal cell carcinoma regrows at or near a spot that was already treated, usually because a few tumor cells were left behind. Warning signs include a new bump, a shiny or scaly patch, or a sore that bleeds, crusts, and won't heal within the old treatment site or scar. Anything changing there deserves a prompt look. Our recurrence-prevention guide covers what to watch for.
Recurrences tend to show up on the head and neck — the nose, ears, eyelids, lips, and scalp — where sun exposure is heaviest and the original tumor borders are hardest to clear. Aggressive growth patterns and larger tumors also raise the odds. New, separate basal cells most often appear on chronically sun-exposed skin. Our guide to how BCC spreads explains why location matters.
The main reason is cumulative lifetime ultraviolet exposure, which damages DNA in skin cells year after year. Fair skin that burns easily, older age, outdoor work or hobbies, past tanning-bed use, earlier radiation therapy, and a weakened immune system all add up. A minority have an inherited condition. Once you've had one BCC, your skin has shown it's prone to more. See lifestyle and prevention.
For most basal cell carcinomas, follow-up is a visual and hands-on skin exam — imaging is rarely needed because BCC almost never spreads internally. Your dermatologist biopsies any new or changing spot that looks suspicious to the eye or under a dermatoscope. Scans like CT or MRI are reserved for the uncommon large, deep, or nerve-involving tumor. Our biopsy guide explains what a biopsy shows.
Once a month, in good light with a full-length and a hand mirror, scan your whole body head to toe — including the scalp, ears, behind the ears, back, buttocks, and soles. Pay closest attention to past treatment sites and sun-exposed areas. Look for new bumps, shiny or scaly patches, and sores that won't heal. Our self-exam guide walks through each step.
A normal surgical scar is flat or slightly firm, pale or pink, and stable or fading month by month. A new or recurrent basal cell tends to do the opposite: it grows, develops a pearly or translucent rim, shows tiny visible blood vessels, or forms a crusting sore that reopens. Anything raised, changing, or bleeding at a scar should be checked. See recovery after surgery.
Dated photos help, especially for spots you're watching and for past treatment sites. Take them in consistent light with a ruler or coin for scale, and compare monthly. Phone apps can organize images, but no app reliably diagnoses skin cancer, so treat their risk scores with caution. Bring anything new or changing to your dermatologist. Our self-exam guide has more tips.
Watch the scar and the skin just beyond its edges. Concerning changes include a new pearly bump, a spreading pink or scaly patch, a raised firm nodule, visible tiny blood vessels, or a sore that crusts and bleeds without healing. Persistent color change or itching also warrants a look. Graft edges are a common spot for regrowth. See recovery after surgery for what normal healing looks like.
Call before your next routine visit if you notice a spot that bleeds easily, a sore that hasn't healed in about a month, a growing or newly raised bump, a pearly or scaly patch, or any change at a past treatment site. It's always reasonable to have one spot checked rather than wait months. Our self-exam guide lists what should prompt a call.
The core habits: broad-spectrum SPF 30 or higher on exposed skin every day, shade between 10 a.m. and 4 p.m., a wide-brimmed hat and sun-protective clothing, and no tanning beds. Reapply sunscreen every two hours outdoors, and don't skip the ears, lips, and back of the neck. Keeping up monthly skin checks catches anything new early. Our lifestyle and prevention guide goes deeper.
Regular sunscreen use has been shown in trials to lower the number of new skin cancers and precancers over time. Choose a broad-spectrum product with SPF 30 or higher; mineral formulas with zinc oxide or titanium dioxide suit sensitive skin. Apply roughly a shot-glass amount for the body, reapply every two hours outdoors, and pair it with shade and clothing. Our prevention hub compares options.
In people with a history of basal or squamous cell carcinoma, a form of vitamin B3 called nicotinamide, taken as 500 mg twice daily, reduced new non-melanoma skin cancers by about 20 percent in a clinical trial. It's inexpensive and generally well tolerated, but it isn't the same as niacin, and the benefit fades once you stop. Ask your dermatologist whether it fits your situation. See recurrence prevention.
Very — fabric and a hat brim block UV consistently, with no reapplication, and cover the areas where basal cells cluster: the scalp, ears, nose, and neck. A wide brim of about three inches shades the face far better than a baseball cap. Clothing labeled UPF 50 blocks most UV. For someone with a skin-cancer history, daily coverage is one of the simplest protections. Our prevention hub has details.
No diet prevents skin cancer, but a few things help overall skin health: not smoking, limiting alcohol, staying hydrated, eating plenty of fruits and vegetables, and managing conditions that weaken immunity. Far more important, protecting skin from UV and keeping up dermatology visits do more than any supplement. Be cautious with unproven "immune-boosting" products. Our lifestyle and prevention guide separates evidence from hype.
Many people find scars fade and flatten substantially over 6 to 12 months, becoming far less noticeable than they first feared. In the meantime, options include silicone gels or sheets, gentle massage once fully healed, camouflage makeup, and later laser or minor revision if a scar stays prominent. Talking with others who've had facial surgery helps too. See recovery after surgery for scar-care basics.
A short, factual line usually works: basal cell carcinoma is a common, highly curable skin cancer from past sun exposure, it's removed in the office, and it doesn't spread internally like other cancers. Explaining that you need frequent skin checks and minor procedures — not chemotherapy — often eases people's worry. Share as much detail as you're comfortable with. Our BCC overview is a useful page to point people to.
Some worry is normal, especially near appointments. It often helps to channel it into things you control: monthly skin checks, sun protection, and keeping every follow-up visit. Remember that most recurrences and new BCCs are caught early and treated simply. If fear disrupts sleep, focus, or mood, a counselor experienced with cancer survivors can help. Our recurrence-prevention guide can make the actual risks feel more concrete.
Give healing time — scars usually soften and blend over the first year. Practical steps help: consistent scar care, sun protection so scars don't darken, clothing or makeup you feel comfortable in, and gradually returning to normal activities and social settings. Some people benefit from talking with a therapist or a survivor support group. See recovery after surgery for what to expect week by week.
Common themes: settling into a predictable skin-check routine so it feels like maintenance rather than crisis, making sun protection an automatic habit, connecting with others who've had similar procedures, and holding on to the fact that basal cell carcinoma is rarely life-threatening. Many say the first year is the hardest and it eases after that. Other questions in this BCC section cover the practical side.
Active areas include hedgehog-pathway drugs for advanced or multiple tumors, immunotherapy such as cemiplimab for cases that can't have surgery or radiation, improved topical and light-based therapies for superficial tumors, and better chemoprevention like nicotinamide. Researchers are also refining Mohs and imaging techniques to clear tumors with less tissue loss. Our treatment options guide covers what's standard now.
Most people with many BCCs simply inherited fair, sun-sensitive skin and have had heavy lifetime UV exposure — not a single "cancer gene." A small number have an inherited syndrome, most notably Gorlin (basal cell nevus) syndrome, that causes numerous BCCs from a young age. Tell your dermatologist if you developed BCCs before age 30 or have a strong family pattern. Our BCC types guide touches on this.
Gorlin syndrome, also called basal cell nevus syndrome, is a rare inherited condition that causes many basal cell carcinomas, often starting in the teens or twenties. Other clues include jaw cysts, small pits on the palms and soles, a larger-than-average head, and certain skeletal findings. Doctors suspect it from this pattern and confirm it with genetic testing. Affected people need frequent skin checks. See BCC types.
Yes. Trials study chemoprevention agents, topical and hedgehog-pathway drugs, immunotherapy, and new surgical or light-based approaches, and some specifically enroll people with frequent BCCs or Gorlin syndrome. Your dermatologist or a nearby academic center can point you to options, and ClinicalTrials.gov lists open studies by location. Our overview of how clinical trials work explains what taking part involves.
Stick to a few trustworthy sources — your dermatology team, major cancer organizations, and physician-reviewed sites — rather than open searches that surface worst-case stories. Set a time limit, write down questions as they come up, and bring them to appointments instead of chasing answers at midnight. Our BCC overview and the rest of this question library are good starting points.
Key questions to understand your SCC diagnosis and treatment plan.
Squamous cell carcinoma is the second most common skin cancer. It begins in the flat squamous cells that form the outer skin surface, most often on the face, ears, lips, scalp, and hands. It grows faster than basal cell carcinoma and, unlike it, can spread to lymph nodes if neglected, though far less readily than melanoma. Our squamous cell carcinoma overview and a comparison of early signs explain the differences.
Compared with basal cell carcinoma, SCC tends to grow more quickly, extends deeper into tissue, and carries a real if modest chance of spreading to nearby lymph nodes. Certain features raise that risk further: large size, location on the ear or lip, poorly differentiated cells, nerve involvement, and a weakened immune system. Most SCCs caught early are still very curable. Our page on recurrence and metastasis risk covers what drives it.
No, though cumulative sun exposure is by far the most common cause, which is why SCC clusters on the head, neck, arms, and hands. Other triggers include indoor tanning, a suppressed immune system (especially after an organ transplant), certain HPV infections, chronic wounds or burn scars, radiation, and arsenic exposure. Many SCCs arise from precancerous actinic keratoses. The prevention guide explains how to lower your risk.
Typical signs include a rough, scaly patch that won't heal, a firm red bump, a sore that crusts, bleeds, or reopens, or a wart-like growth. Some develop within a pre-existing rough spot. They often feel tender and may grow over weeks to months. Any lesion that changes, bleeds easily, or persists beyond a month deserves a look. Compare SCC with other skin cancers in our early-signs guide.
Differentiation describes how closely the tumor cells still resemble normal squamous cells under the microscope. Well-differentiated SCC looks close to normal and usually behaves less aggressively. Poorly differentiated SCC looks disorganized, tends to grow and recur more readily, and is more likely to spread. Moderately differentiated falls in between. This grade is one factor doctors weigh alongside size, depth, and location. Our staging and grading page explains how it's used.
The dermatologist reviews the pathology report and classifies the tumor as low- or high-risk based on size, depth, location, grade, and your immune status. Most low-risk SCCs are removed in the office with surgical excision or Mohs surgery. High-risk tumors may prompt imaging, a lymph node exam, or referral to a Mohs surgeon or multidisciplinary team. Our treatment options page walks through each path.
A general or Mohs-trained dermatologist handles most cases. Larger or facial tumors may involve a Mohs surgeon, a reconstructive or plastic surgeon, or an oculoplastic or ENT surgeon for delicate areas. High-risk or advanced disease can bring in a radiation oncologist, a medical oncologist for immunotherapy, and a pathologist reading the tissue. A primary care doctor often coordinates follow-up. Our follow-up care page describes who does what.
They use criteria from groups like the NCCN. Features that push a tumor into the high-risk category include diameter over about 2 centimeters, invasion into deeper layers, poorly differentiated cells, growth around nerves, location on the ear, lip, or a scar, rapid growth, recurrence, and a suppressed immune system. Everything else is generally low-risk. The category guides how widely the tumor is removed and whether extra staging and testing follows.
Imaging isn't routine for skin cancer, but doctors order it when a tumor is large, deep, fixed to underlying tissue, growing near nerves, or recurrent, or when lymph nodes feel enlarged. A CT or MRI shows how far the cancer extends, whether it involves bone or nerves, and whether nodes or distant sites are affected. The results help plan surgery and decide if radiation or drug therapy is needed.
Mohs is favored when tissue preservation and the highest cure rate matter most: tumors on the face, ears, lips, nose, hands, feet, or genitals; large or poorly defined lesions; aggressive growth patterns; perineural invasion; recurrent SCC; and tumors in people with weakened immunity. The surgeon removes tissue in thin layers, checking each one under the microscope until margins are clear. See which spots count as high-risk locations.
Options depend on risk. Surgical excision cuts out the tumor with a margin of normal skin and stitches the wound. Mohs surgery maps margins layer by layer for high-risk or cosmetically sensitive sites. Curettage and electrodesiccation scrapes and burns small, superficial low-risk lesions. Radiation treats tumors that can't be operated on or adds control afterward. Advanced disease may use immunotherapy. See our treatment options page for details.
During Mohs, the surgeon removes the visible tumor plus a thin surrounding layer, then examines the entire edge under a microscope while you wait. If cancer remains, only the involved area is taken again, sparing healthy tissue. On the ear, lip, or nose there's little skin to spare and tumors can send out roots, so this precise, same-day margin check gives the highest cure rate with the smallest defect.
Standard excision is a one-time surgery: the doctor numbs the area, cuts out the tumor with a measured margin, and closes it, with pathology confirming clear edges days later. Radiation therapy uses focused X-ray beams over several sessions across weeks, with no cutting. Surgery is faster, gives immediate margin information, and is usually first choice. Radiation suits people who can't have surgery or need extra treatment for high-risk features. Our treatment options page compares them.
Doctors examine the lymph nodes near a high-risk SCC — those that are large, deep, poorly differentiated, recurrent, on the ear or lip, or growing around nerves, and any SCC in someone immunosuppressed. If a node feels firm or enlarged, an ultrasound or needle biopsy checks it. Sentinel node biopsy is sometimes considered for very high-risk tumors, though it's less established than in melanoma.
Perineural invasion means cancer cells are tracking along or around a nerve, seen on the pathology slide. It signals a higher chance of local recurrence and spread because tumor can travel unseen along the nerve. Treatment often becomes more aggressive: Mohs or wider excision, imaging such as MRI to trace the nerve, and radiation after surgery when larger nerves are involved. It's one of the standard high-risk features.
Many people find it helps to remember that most SCC is caught early and cured with a single office procedure. Keeping busy, exercising, limiting how often you search online, and setting a specific time to call the office with questions all reduce the spin. Writing down your questions for the next visit gives the worry somewhere to go. If anxiety disrupts sleep or daily life, tell your care team.
Expect some swelling, bruising, and tightness for one to two weeks, more around the eyes if the wound is on the forehead or cheek. Scalp wounds ooze a little and feel tender against a pillow. You'll keep the site clean and covered, use petrolatum ointment, avoid heavy lifting and bending for about two weeks, and return for suture removal. Full scar maturation takes months. Our follow-up care page covers aftercare.
Talking with the surgeon before the procedure about how the wound will be closed, where the scar line will fall, and whether a reconstruction specialist should be involved sets realistic expectations. Fresh scars look their worst early and keep improving for a year. Sun protection, gentle massage once healed, and silicone gel or sheets can help. Laser treatment or scar revision is an option later if a scar stays noticeable.
Yes. A cancer diagnosis of any kind stirs that fear, and it usually eases once you understand your specific tumor. For most SCC the odds of spread are low — only a few percent overall, and lower still for small, low-risk tumors removed with clear margins. Ask your doctor which risk category yours falls in. Our page on recurrence and metastasis risk explains the numbers in plain terms.
It often helps to lead with the reassuring facts: this is a common skin cancer, it was caught on the skin, and the plan is a minor procedure to remove it. Share what you know about the risk category and the timeline, and let them ask questions. Being matter-of-fact models calm. If children are involved, simple, concrete language about a spot the doctor is taking off usually lands best.
Useful questions: How wide is the tumor, and how deep did it go? Is it well, moderately, or poorly differentiated? Did it reach the fat, muscle, cartilage, or bone? Is there invasion around nerves or blood vessels? Does this make it low-risk or high-risk, and why? Knowing these answers helps you understand the plan and follow-up. Our staging and grading page defines each term.
Margin status tells you whether normal tissue surrounded the tumor on every side of the removed specimen. A clear or negative margin means no cancer was seen at the edge and the excision is likely complete. A positive or involved margin means tumor reached the cut edge, so more surgery or radiation is usually recommended. Mohs surgery checks 100 percent of the margin, versus a sampling in standard excision.
Bring a written list of questions, the name and dose of any blood thinners or supplements you take, and a note of any fever, spreading redness, drainage, or pain since surgery. Ask what the final pathology showed, whether margins were clear, when stitches come out, how to care for the scar, and what the follow-up schedule looks like. Our follow-up care page outlines the routine.
A second opinion is reasonable any time and never offends a good doctor. People commonly seek one for a high-risk or recurrent tumor, when surgery would be extensive or affect the face, when treatment options seem unclear or in conflict, when the diagnosis is uncertain, or simply for peace of mind before proceeding. Academic dermatology and cancer centers offer them routinely, and most tumors allow time to arrange it.
Ask the doctor to explain each option's goal, cure rate, number of visits, recovery, scar, and risks, and to say which they recommend and why. Repeat it back in your own words to check. Request written materials, take notes or record the visit with permission, and bring a family member. If anything stays fuzzy, a follow-up call or second opinion can fill the gaps. Browse the rest of this SCC question library for more.
Questions for surveillance, prevention, and managing ongoing care.
After one squamous cell carcinoma, most dermatologists do a full skin exam every 6 to 12 months for the first few years, because the risk of a second skin cancer is highest early on. People with several past SCCs, large or aggressive tumors, or a suppressed immune system are often seen every 3 to 6 months. As your skin stays clear, visits usually spread out. Our follow-up care guide explains typical schedules.
Recurrence means squamous cell carcinoma regrows at or beside a spot that was already treated, usually because a few tumor cells escaped removal. It most often appears in or around the original scar as a new lump, a scaly or crusted patch, or a sore that won't heal. Recurrences are most common in the first two years and on the head and neck. Our recurrence and metastasis guide has details.
Once you've had several squamous cell carcinomas, dermatologists usually shorten the gap between skin exams — often to every 3 to 4 months — because each new SCC raises the odds of the next. They may also add lymph node checks, photograph high-risk areas, and treat sun-damaged "field" skin more aggressively. As clear intervals add up, visits can gradually lengthen again. Our follow-up care guide outlines how schedules are set.
The most common sign is a firm, painless lump under the skin near the original tumor — often in the neck, in front of or behind the ear, in the armpit, or in the groin. A node that keeps enlarging over weeks, feels fixed in place, or comes with numbness or tingling deserves prompt evaluation. Most SCCs never spread. Our recurrence and metastasis guide explains who is at higher risk.
Tumors on the ear, lip, temple, and scalp behave more aggressively because the skin there is thin, sits close to nerves and cartilage, and drains quickly to nearby lymph nodes. These sites also see heavy lifelong sun and can hide tumors under hair or in folds, so they're often found later and larger. Doctors watch them closely and may treat more thoroughly. Our high-risk locations guide explains more.
Once a month, in good light with a hand mirror, look over your whole body — including the scalp, ears, lips, backs of the hands, and any old treatment scars. You're watching for rough or scaly patches, new firm bumps, and sores that bleed or won't heal within a few weeks. Photos help you compare over time. Our self skin check guide walks through the routine.
"Field cancerization" means a broad area of skin — not just one spot — has been damaged by years of sun and carries many cells on the path toward cancer. That's why people with one SCC often keep getting actinic keratoses and new SCCs nearby. Care shifts from treating single lesions to treating the whole zone with creams, light therapy, or peels. Our actinic keratosis overview covers field treatment.
Yes. Many people take dated smartphone photos of their skin every month or two, using a consistent distance and lighting, plus close-ups of scars and problem areas. Some clinics offer total-body photography for people with lots of sun damage. Phone apps that "grade" moles can miss cancers, so use photos as a memory aid, not a diagnosis. Our self skin check guide has tips.
A good rule is the "won't heal in a month" test: any scaly patch, sore, or scab that keeps coming back, grows, thickens, bleeds, or becomes tender over about four weeks should be seen. Old scars that suddenly develop a firm nodule, raised edge, or new ulcer also warrant a look. When in doubt, ask sooner. Our early signs guide shows what these look like.
Skin that was treated with radiation years ago, or a long-standing burn scar, ulcer, or wound, can develop SCC slowly. Watch that area for a new firm bump, a thickened or raised rim, an ulcer that won't close, or bleeding and pain that weren't there before. Changes may be subtle, so photograph the site and mention any history of radiation or chronic wounds to your dermatologist. Our high-risk locations guide covers this.
Daily sun protection is the biggest lever: broad-spectrum SPF 30+ sunscreen, shade at midday, wide-brimmed hats, and UPF clothing, plus no tanning beds. Treating actinic keratoses early, keeping any prescribed field creams going, and having regular skin exams all help. If you take immune-suppressing medicine, ask whether the dose can be adjusted. Our SCC prevention guide covers each step in detail.
Most dermatologists suggest a broad-spectrum sunscreen of SPF 30 or higher applied every morning to the face, ears, neck, scalp part line, and hands, then reapplied every two hours outdoors or after swimming or sweating. Use about a teaspoon for the face and neck alone. Sunscreen works best alongside shade and clothing, not instead of them. Our prevention hub has a full sun-safety routine.
Nicotinamide is a form of vitamin B3 (not niacin) sold over the counter. In studies of people with many past skin cancers, taking 500 mg twice daily modestly lowered the rate of new SCCs, basal cell cancers, and actinic keratoses. The benefit fades if you stop, and it isn't right for everyone, so ask your dermatologist before starting or changing any supplement.
A healthy immune system spots and clears many damaged, precancerous skin cells before they grow. Drugs that dampen immunity — anti-rejection medicine after an organ transplant, or treatments for autoimmune disease — remove some of that surveillance, so SCC can appear more often, at younger ages, in greater numbers, and behave more aggressively. Close skin monitoring and, where possible, adjusting the regimen help. Our metastasis risk guide covers high-risk groups.
For everyday wound healing, the basics matter most: eat enough protein, fruits, and vegetables, stay hydrated, don't smoke, limit alcohol, and manage conditions like diabetes. Keep treated sites clean and moist as instructed. Beyond correcting a true deficiency, high-dose vitamin supplements haven't been shown to speed healing. Nicotinamide is studied for preventing new SCCs, not for healing wounds. Our treatment options guide covers aftercare.
Many people find it helps to keep a simple calendar so appointments feel routine rather than alarming, to bring a friend to visits, and to schedule something pleasant afterward. Ask your dermatologist to explain what each biopsy or excision involves so there are fewer surprises. If worry lingers between visits, a counselor or a skin-cancer support group can help. Our follow-up care guide explains what to expect.
It helps to remember that most squamous cell carcinomas found early are cured with a single office procedure, and that regular checks are what keep them small. Many people reframe surveillance as maintenance, like dental cleanings. Focusing on what you can control — sun habits, field treatments, keeping appointments — restores a sense of agency. Support groups and honest talks with your dermatologist ease the load. Our SCC overview puts the outlook in context.
You might say that squamous cell carcinoma is a common skin cancer that is almost always cured when caught early, usually with a minor procedure — but that because sun damage is widespread, new spots can keep forming, so regular dermatologist visits and monthly skin checks are part of life now. Framing it as manageable, ongoing care rather than a crisis tends to reassure people.
A monthly routine, not daily inspection, is usually enough. Learn the few changes that matter — a scaly patch, sore, or bump that grows or won't heal in about a month — and let smaller day-to-day variations go. Dated photos let you compare objectively instead of relying on memory. Between checks, trust the schedule your dermatologist set. Our self skin check guide keeps the routine simple.
Beyond your dermatologist, high-volume patients often benefit from a "high-risk skin cancer" or transplant-dermatology clinic, where field therapies, oral options like nicotinamide or acitretin, and closer surveillance are coordinated. Nonprofit groups such as the Skin Cancer Foundation and AIM at Melanoma offer education and peer support. A medical oncologist joins the team if a tumor becomes advanced. Our follow-up care guide describes coordinated monitoring.
For SCC that keeps coming back or has spread, options have grown well beyond surgery and radiation. Immunotherapy drugs that release the immune system's brakes (checkpoint inhibitors) can shrink many advanced tumors. Targeted approaches, combined chemoradiation, and clinical-trial agents are used in select cases, often guided by a multidisciplinary tumor board. Most early SCCs never need these. Our treatment options guide reviews the full range.
Cemiplimab is a checkpoint inhibitor — an antibody given by IV that blocks a switch (PD-1) tumors use to hide from immune cells, letting the body attack the cancer. It's generally considered for SCC that is metastatic or locally advanced and can't be fully removed by surgery or treated with radiation. Response rates are meaningful but not universal, and immune side effects need monitoring.
"Locally advanced" means the tumor has grown large or deep into nearby tissue — muscle, cartilage, bone, or nerve — so it can't be removed cleanly or treated with straightforward radiation, but it hasn't traveled elsewhere. "Metastatic" means SCC cells have spread through lymph or blood to lymph nodes or distant organs such as the lungs. Both are uncommon and change the treatment plan. Our staging and grading guide explains the terms.
Yes. Active trials are testing immunotherapy before or after surgery, drug combinations for advanced disease, new targeted agents, and prevention strategies for people with many SCCs or transplants. Your dermatologist or a medical oncologist can check whether you qualify, and ClinicalTrials.gov lists open studies by location. Joining is voluntary and includes close monitoring. Our guide to clinical trials explains how they generally work.
Pick a few trustworthy sources and check them occasionally rather than searching daily. Reputable options include the American Academy of Dermatology, the Skin Cancer Foundation, and the patient sections of major cancer centers. Bring specific questions to your appointments and ask your dermatologist what's worth reading for your situation. Set limits on late-night searching. Our SCC overview and its linked guides are a calm starting point.
Questions about precancerous lesions and how to manage them effectively.
An actinic keratosis (AK) is a rough, scaly patch on skin damaged by years of sun or tanning beds. Doctors call it a "precancer" because some of its cells carry early changes that can, over time, progress into squamous cell carcinoma. Most AKs never become cancer, but there's no reliable way to tell which will, so they're watched or treated. See our AK vs. skin cancer guide.
Ultraviolet light damages the DNA inside skin cells called keratinocytes. Most damage is repaired, but decades of exposure let mutations build up in a patch of skin. Those cells start growing abnormally, producing the dry, scaly surface of an AK. The surrounding area, often called "sun-damaged" or "field" skin, carries similar hidden changes even where it looks normal. This is why AKs tend to appear in clusters on the face, scalp, ears, and hands.
Very common. Because ultraviolet damage affects a whole region of skin, not a single point, most people with one AK have several. It's typical to find a handful to dozens scattered across the scalp, forehead, ears, forearms, and backs of the hands. When many lesions cluster in one sun-damaged area, dermatologists often treat the entire region rather than each spot. Our field therapy guide explains that approach.
A typical AK is a small patch, often less than a quarter-inch, with a rough, dry, or sandpapery texture — sometimes easier to feel than to see. Colors range from skin-toned to pink, red, or brownish, and the surface may be scaly or crusty. Some feel tender, itchy, or prickly. They favor sun-exposed areas. A thick, hard, or rapidly growing bump should be shown to a dermatologist. Compare features in our actinic keratosis overview.
Some AKs do fade on their own, especially if sun exposure drops, and studies show a fair number clear over a year. But many of those return, and a small share progress toward squamous cell carcinoma. Because no one can predict which lesions will regress and which will advance, dermatologists usually treat AKs or keep them under close watch rather than ignoring them. Our treat now vs. watch guide weighs the options.
It means the abnormal cells in an AK sit on a spectrum. In an AK, the changes stay in the top layer of skin. If more mutations accumulate, those cells can break through into deeper tissue and become an invasive squamous cell carcinoma (SCC), a common skin cancer. Some experts even consider AK the earliest form of SCC. Treating an AK removes those cells before that step can happen.
For any single AK, the risk of becoming squamous cell carcinoma in a year is low — commonly estimated at well under 1 percent. But people often carry many AKs for years, so the combined risk adds up, and most SCCs on sun-damaged skin arise from a pre-existing AK. Progression, when it happens, usually takes years. Immune-suppressed people move faster. Our progression risk guide covers the numbers.
The biggest factor is lifetime ultraviolet exposure, so people who worked or played outdoors for years, or used tanning beds, accumulate more. Fair skin that burns easily, light eyes, blond or red hair, older age, living closer to the equator, and a history of blistering sunburns all raise the odds. A weakened immune system — from an organ transplant or certain medications — sharply increases both AK numbers and their risk of progressing.
Yes. People with fair skin that freckles or burns rather than tans have less protective pigment, so ultraviolet reaches and damages deeper cells more easily. Years of deliberate tanning — outdoors or in a bed — deliver a large ultraviolet dose and strongly raise AK risk. Darker skin can still develop AKs but far less often. Past tanning can't be undone, but consistent sun protection from now on slows new damage.
Usually yes. Treatment clears the visible lesions, but the surrounding skin still carries the sun damage that produced them, so new AKs commonly appear over months and years. This is expected, not a sign that treatment failed. It's the main reason dermatologists schedule regular skin checks and often recommend field treatment plus daily sun protection. Our monitoring schedule guide explains typical follow-up.
Freezing (cryotherapy) with liquid nitrogen destroys a lesion by frosting it; the spot blisters, scabs, and falls off. Prescription creams — such as 5-fluorouracil or imiquimod — are rubbed over an area for days to weeks and make damaged cells inflame and shed. Photodynamic therapy applies a light-activated solution, then a special lamp to clear a whole region. Chemical peels and scraping are also used. Our treatment options guide compares them.
Spot treatment, like freezing a single lesion, targets only what the doctor can see and feel. Field therapy treats an entire sun-damaged region — say the whole scalp or both forearms — with a cream, gel, or photodynamic light. Because it also hits early lesions too small to notice, field therapy tends to lower the number of AKs that appear later. Our field therapy guide covers when it's chosen.
All three can clear a large share of AKs in a treated area, but they differ. 5-fluorouracil is generally the most effective, often clearing well over half of lesions, followed by imiquimod; diclofenac gel is the gentlest and the least powerful. Stronger creams cause more redness, crusting, and soreness during the weeks of use. Results vary, and more than one course is often needed. Your dermatologist can set expectations for your skin.
PDT treats a whole sun-damaged area at once. A dermatologist applies a solution that damaged cells absorb, waits while it builds up, then shines a specific light that activates it and destroys those cells. During the light exposure many people feel stinging or burning. Afterward the area looks sunburned — red, swollen, and peeling — for several days to a week, and must be kept out of sunlight. Our treatment options guide explains more.
They weigh how many AKs you have and whether they're scattered or clustered, where they sit, how thick they are, your skin type, past treatments, other health conditions, and how much downtime you can manage. A few isolated spots are often frozen in the office; widespread damage points toward a cream or light therapy. Cost, insurance, and your preferences matter too. Our talking to your doctor guide lists questions to raise.
The core habit is limiting ultraviolet exposure every day, not just at the beach. Seek shade around midday, wear a broad-brimmed hat and long sleeves, use a broad-spectrum sunscreen on exposed skin, and skip tanning beds entirely. Sunglasses and lip balm with SPF protect commonly missed spots. Keeping up with dermatology visits and treating sun damage early also helps. Our prevention and sun protection guide puts it together.
It matters a lot. Trials in people with sun-damaged skin found that regular daily sunscreen use produced fewer new AKs and even some clearing of existing ones over time, compared with occasional use. Sunscreen works best as one layer of protection alongside shade and clothing, since no product blocks all ultraviolet and most people apply too little. Consistency — every day, reapplied outdoors — is what drives the benefit. See our prevention overview.
Dermatologists generally suggest a broad-spectrum sunscreen — meaning it covers both UVA and UVB — with SPF 30 or higher for daily use, and SPF 50 for extended time outdoors. Mineral formulas with zinc oxide or titanium dioxide suit sensitive or reactive skin and skin healing after treatment. The best sunscreen is one you'll apply generously and reapply every two hours outdoors. Ask your dermatologist what fits your routine.
A lot. Tightly woven or UPF-rated clothing and a broad-brimmed hat physically block most ultraviolet across the skin they cover, all day, with no need to reapply — something sunscreen can't match in real-world use. Shade cuts exposure sharply, though scattered sky and reflected light still reach you. The strongest protection layers all of them together, with sunscreen filling the gaps on the face, ears, neck, and hands. Our prevention overview explains the mix.
There's real evidence for it. In people with a strong history of sun damage or prior skin cancers, studies of nicotinamide 500 mg twice daily showed modestly fewer new AKs and fewer new basal and squamous cell cancers. It's inexpensive and generally well tolerated, but the benefit is partial and stops when you stop taking it. Nicotinamide is different from niacin. Ask your dermatologist whether it fits your situation.
A quick self-check about once a month works well for most people — look over the scalp, face, ears, neck, arms, and hands in good light, using a mirror or a partner for hard-to-see spots. Note anything new, growing, bleeding, or not healing. This is in addition to the professional skin exams your dermatologist schedules, often every 6 to 12 months. Our monitoring schedule guide outlines typical timing.
Treated spots normally heal to smooth, slightly pale, or pink skin within a few weeks. Afterward, watch for a patch that turns rough or scaly again, a sore that won't heal, a lump that thickens or grows, or a spot that bleeds or crusts repeatedly. Any of these can mean the AK persisted or a new lesion formed. Compare these against normal healing in our early signs of SCC guide, and report them promptly.
Some redness, flaking, and crusting is normal for days to a few weeks after treatment, then settles. Contact your dermatologist if a treated spot stays rough or scaly beyond the expected healing time, thickens into a bump, forms a sore that won't close, or bleeds without clear cause. Also call sooner if it becomes very painful, swollen, or oozing, which can signal infection. Our talking to your doctor guide can help you describe changes.
Most dermatologists advise getting vitamin D from diet and supplements rather than deliberate sun exposure, because the ultraviolet dose that makes vitamin D also drives AKs and skin cancer. Incidental daily light on the hands and face, plus foods like fatty fish or fortified milk, cover many people; a supplement reliably fills any gap. A simple blood test can check your level. Our sun protection guide discusses this trade-off.
Treat sun protection as a daily routine in every season: sunscreen on exposed skin, a hat and sunglasses, shade at midday, and UV-aware clothing, remembering that snow, water, and altitude all boost exposure. Skip tanning beds. Keep regular dermatology appointments and treat AKs early. Gentle skin care — moisturizer, not scrubbing — and not smoking also support healing. Our actinic keratosis overview pulls the pieces together.
Essential questions for protecting your skin and reducing your risk.
Ultraviolet light penetrates skin cells and damages their DNA directly. Most damage is repaired, but some errors slip through and accumulate with every sunburn and every hour outdoors. When enough builds up in genes that control cell growth, a cell can begin dividing without limits — the start of a skin cancer. A tan is itself a sign of DNA injury. Our prevention overview explains the process.
There's no single safe number, but the fairer your skin, the faster it burns and the less ultraviolet it takes to cause damage. People who freckle, have red or blond hair, or rarely tan reach their limit within minutes on a strong summer day; darker skin has more built-in protection but still accumulates damage and can develop skin cancer. The practical goal for everyone is avoiding any redness or burning.
Both come from the sun. UVB is the shorter wavelength that causes sunburn and most directly damages DNA in the outer skin. UVA penetrates deeper, drives premature aging and wrinkling, and also contributes to cancer; it passes through clouds and window glass and stays fairly constant through the day. Because they act differently, dermatologists recommend "broad-spectrum" products, which are tested to block both. Our prevention overview covers what that label means.
Sunscreens either absorb ultraviolet and release it as heat (chemical filters) or sit on the surface and scatter it (mineral filters like zinc oxide). Either way, the film has to be thick and even to deliver its rated SPF. Most products stay stable until the printed expiration date, usually two to three years; toss any that have changed color, texture, or smell, or that were left in a hot car.
A few worth dropping: that a "base tan" protects you (it offers about SPF 3 and is already DNA damage), that you can't burn on cloudy or cold days (UV passes through clouds and reflects off snow), that darker skin doesn't need protection, and that tanning beds are a safe way to top up vitamin D. Our prevention overview sorts fact from fiction.
Most people succeed by attaching it to something they already do every morning — brushing teeth, moisturizing, or getting dressed — and keeping the bottle where they'll see it. A moisturizer or tinted product with SPF 30+ built in removes a step for the face. Leaving a second tube in your car, bag, or desk covers reapplication. The habit matters more than the specific product.
The standard guidance is about one ounce — a full shot glass — for the exposed body in a swimsuit, and roughly a nickel-sized blob for the face alone. Most people apply a quarter to half of that, which cuts the real-world SPF sharply. A useful check for the face and neck is "two finger-lengths" of product squeezed onto two fingers. Apply 15 minutes before going outside.
About every two hours of continuous sun, and immediately after swimming, heavy sweating, or toweling off — even "water resistant" products are only tested to hold up for 40 or 80 minutes in water. If you're mostly indoors with brief outdoor trips, a single morning application usually lasts, though reapplying at midday is reasonable on high-UV days. Sprays and sticks make touch-ups over sunscreen easier.
Only slightly on paper: SPF 50 blocks about 98% of UVB and SPF 100 about 99%. The bigger issue is that a higher number can create false confidence, leading people to stay out longer or skip reapplication. A well-applied SPF 30 to 50, reapplied on schedule and paired with shade and clothing, protects better than SPF 100 used carelessly. Choose a number you'll actually reapply.
Both are considered effective when they're broad-spectrum and applied properly. Mineral (zinc oxide, titanium dioxide) sits on the surface, works immediately, and tends to suit sensitive, rosacea-prone, or post-procedure skin, though it can leave a white cast. Chemical filters are lighter and blend clear, which many people prefer for daily wear under makeup. Our sun protection guide compares them in more detail.
Tightly woven, dark or bright fabrics block more ultraviolet than loose, light-colored, or stretched material, and coverage counts — long sleeves and long pants beat a tank top. A broad-brimmed hat (about three inches all around) shades the ears and neck far better than a baseball cap. Purpose-made clothing carries a UPF rating, with UPF 50 blocking roughly 98%. Our prevention overview has more.
Check the label or hang tag for a "UPF" number — ordinary clothing isn't rated even though it still blocks some UV. As a rough test, hold a garment up to a bright light: the less light passes through, the more UV it stops. Wash-in products like Rit Sun Guard add UPF to regular clothes for roughly 20 washes. Darker colors and a tighter weave also raise protection.
UV peaks roughly from 10 a.m. to 4 p.m., when the sun is highest and its rays pass through the least atmosphere — often 60% or more of the day's total dose falls in that window. A quick rule: if your shadow is shorter than you are tall, UV is intense. It's also stronger at high altitude, near the equator, and around water, sand, and snow. Our prevention overview explains the UV Index.
You don't have to stay inside. Plan strenuous or long outings for early morning or late afternoon, take breaks in shade, and set up an umbrella or canopy at the beach or field. Wear a hat, sunglasses, and a UPF shirt, and put sunscreen on the spots clothing misses. Check the day's UV Index, and keep water handy since heat and sun exposure often go together.
A windshield is laminated and blocks almost all UVA and UVB, but side and rear windows usually stop only UVB, letting UVA through — which is why long-time drivers often show more sun damage and skin cancer on the left side of the face and arm. Ordinary indoor light and computer screens emit negligible UV. If you drive a lot, consider UV-filtering window film or a long sleeve.
Get familiar with your own skin so you notice when something is new or different. The general signals are a mole that changes in size, shape, or color; a spot that looks unlike your others; and any sore that bleeds, crusts, or won't heal within a month. Photos help you compare over time. Our guide to warning signs of melanoma change shows what to watch for.
It's a memory aid for melanoma warning signs. A is asymmetry (one half unlike the other); B is an irregular or blurred border; C is more than one color or uneven color; D is diameter larger than a pencil eraser (about 6 mm); E is evolving — any change over weeks or months. E matters most. Show a dermatologist anything that fits. Our melanoma overview has examples.
About once a month is the common recommendation — often enough to catch a change, spaced enough that differences stand out. A thorough check takes 10 to 15 minutes in a well-lit room with a full-length and a hand mirror, going head to toe including the scalp, between toes, soles, and back. A partner helps with hard-to-see areas. Our self-skin check guide walks through the steps.
Use consistent lighting and distance, a plain background, and the same body positions each time. Take wide shots of each region, then close-ups of specific spots with a ruler or coin beside them for scale. Keep phone flash off if it washes out detail. Label photos by date and location, and repeat every few months. Our guide to tracking changes over time covers this.
Trust the "new, changing, or not healing" test. Book a visit for any spot that has appeared or changed over recent weeks, a sore that hasn't healed in a month, a mole that itches or bleeds, or anything that simply looks different from your other spots. It's reasonable to ask for a full skin exam. Our guide on when to see a doctor lists the triggers.
The evidence here is modest. A diet rich in fruits, vegetables, and healthy fats supplies antioxidants that may slightly blunt UV-related stress, and staying hydrated supports normal skin repair. But no food, drink, or supplement provides meaningful sun protection or reverses accumulated damage — the effect is small next to sunscreen, shade, and clothing. Beta-carotene and similar pills haven't been shown to prevent skin cancer.
Vitamin D supports bone strength and immune function, and skin makes it when exposed to UVB. But the dose that damages skin and the dose that makes vitamin D overlap, so dermatologists generally advise getting it from food (fatty fish, fortified milk and cereal) and a supplement rather than deliberate sun. A blood test can check your level. Our sun protection guide discusses the trade-off.
Smoking is linked most clearly to squamous cell carcinoma, especially on the lips and mouth, and it slows wound healing after skin surgery. Heavy alcohol use is associated with a higher risk of melanoma and other skin cancers, possibly because it generates cell-damaging byproducts and can lead to more sunburns. Neither causes skin cancer the way UV does, but both add to the burden. Our SCC prevention guide has more.
Habits set in childhood tend to stick, and early sunburns carry outsized risk. Make protection routine and low-drama: hats and UPF swim shirts as normal gear, sunscreen as part of getting ready, shade and water breaks built into outings, and no tanning beds ever. Kids copy what adults do, so protecting yourself openly teaches more than reminders. Schools and camps often welcome sunscreen if you send it.
A few seconds each morning for SPF on the face, ears, and neck; sunglasses and a hat by the door; choosing the shady side of the street; keeping sleeves on in the car; skipping the tanning bed; and a quick skin glance in the mirror each month. None is dramatic, but repeated over decades they meaningfully lower skin cancer and aging. Our prevention overview ties them together.
Use these questions with our AI guide to get personalized, physician-quality answers tailored to your situation.
Chat with the Navigator